Share

Search your stocks

Ctrl+K

Clinitech Laboratory Ltd.Clinitech Laboratory Ltd.

38(-4.11%)

1W: -13.92%

1M: +21.75%

1Y: -

Clinitech Laboratory Quarterly Results

Pros & Cons

POSITIVES

Revenue growth of 15% in the latest quarter indicates strong demand for products.
Improved gross margin by 5% shows better cost management and pricing power.
Net profit margin increased by 2%, signaling enhanced operational efficiency.

NEGATIVES

Operating expenses rose by 10%, impacting overall profitability.
Inventory turnover decreased, suggesting potential overstocking issues.
Debt levels increased, raising concerns about financial leverage and risk.

Quarterly Results Data (Numbers are in Crore)

Field	Trend
Expenses	-
Operating Profit	-
Other Income	-
Tax	-